Cguard Prime Carotid Stent System
Payments companies reported to CMS as associated with Cguard Prime Carotid Stent System. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Cguard Prime Carotid Stent System, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Cguard Prime Carotid Stent System
These are the largest totals companies reported as associated with Cguard Prime Carotid Stent System. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Peter Soukas | Providence, RI | Interventional Cardiology | $514,784.86 |
| David Metzger | Kingsport, TN | Cardiovascular Disease | $122,359.18 |
| Kenneth Rosenfield | Boston, MA | Cardiovascular Disease | $61,009.61 |
| Adnan Siddiqui | Williamsville, NY | Neurological Surgery | $60,535.29 |
| Sammy Eghbalieh | Porter Ranch, CA | Vascular Surgery | $1,538.04 |
| Gary Roubin | Birmingham, AL | Interventional Cardiology | $1,372.74 |
| Johnathon Rollo | Los Angeles, CA | Vascular Surgery | $1,121.08 |
| Patrick Muck | Cincinnati, OH | Vascular Surgery | $1,098.12 |
| Bradley Boone | Georgetown, TX | Vascular Surgery | $982.01 |
| Felix Song | Honolulu, HI | Neuroradiology | $916.22 |
Prescribed Cguard Prime Carotid Stent System?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.